Sativex | search
Click here to view Sativex news from 60+ newspapers.
Bookmark or Share- Sativex Oromucosal Spray - Summary of Product Characteristics (SmPC ...Sativex is intended to be used in addition to the patient's current anti-spasticity medication. Treatment must be initiated and supervised by a physician with specialist expertise in treating this patient population. Adults:
- [Product Monograph Template - Standard]SATIVEX® (delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)) is indicated as: an adjunctive treatment for symptomatic relief of spasticity in patients with multiple sclerosis (MS) who have not responded adequately to other therapy and who demonstrate
- Sativex® (nabiximols) cannabinoid oromucosal spray in patients with ...This retrospective study evaluates patient-reported outcomes in patients with multiple sclerosis (MS) spasticity who were treated with a cannabinoid oromucosal spray (Sativex®, USAN name: nabiximols) after not sufficiently responding to previous anti-spasticity medications.
- What Is Sativex? (Nabiximols) - MS Treatments | MS SocietySativex is the brand name for a cannabis-based a drug called nabiximols. It’s the only drug in the UK with a licence to treat muscle stiffness and spasms (spasticity) caused by MS.
- What's Sativex And How Does It Differ From Medical Cannabis?Sativex, also known as nabiximols, harnesses a duo of cannabinoids to relieve the symptoms of several medical conditions. It comes in the form of an oral mucosal spray, with each 10ml bottle containing precisely 270mg of THC and 250mg of CBD.
More
